PubIndex
Search
Leaderboards
Bookmark
My Library
Sign in
Back
Cell Signaling Technology
PATL1/PAT1b (D8P1B) Rabbit Monoclonal Antibody
#14288 · $161
56
Citing papers
1.5k
Combined citations
Copy product info
Export PDF dossier
Supplier page
Find this product
Research areas
Histone Deacetylase Inhibitors Research
7
Heart Failure Treatment and Management
5
Ubiquitin and proteasome pathways
4
Peptidase Inhibition and Analysis
4
Cancer Cells and Metastasis
4
Autophagy in Disease and Therapy
4
Protein Degradation and Inhibitors
4
Hearing, Cochlea, Tinnitus, Genetics
3
Papers citing this product
1
Synthetic RNA–protein modules integrated with native translation mechanisms to control gene expression in malaria parasites
Nature Communications
·
2016
·
226 cit.
·
DOI
2
Human ALS/FTD brain organoid slice cultures display distinct early astrocyte and targetable neuronal pathology
Nature Neuroscience
·
2021
·
169 cit.
·
DOI
3
Mitochondrial Localization of ABC Transporter ABCG2 and Its Function in 5-Aminolevulinic Acid-Mediated Protoporphyrin IX Accumulation
PLoS ONE
·
2012
·
136 cit.
·
DOI
4
An Overgrowth Disorder Associated with Excessive Production of cGMP Due to a Gain-of-Function Mutation of the Natriuretic Peptide Receptor 2 Gene
PLoS ONE
·
2012
·
122 cit.
·
DOI
5
Chemoresistance in the Human Triple-Negative Breast Cancer Cell Line MDA-MB-231 Induced by Doxorubicin Gradient Is Associated with Epigenetic Alterations in Histone Deacetylase
Journal of Oncology
·
2019
·
72 cit.
·
DOI
6
A novel loss-of-function mutation in Npr2 clarifies primary role in female reproduction and reveals a potential therapy for acromesomelic dysplasia, Maroteaux type
Human Molecular Genetics
·
2012
·
69 cit.
·
DOI
7
Autophagy activation promotes bevacizumab resistance in glioblastoma by suppressing Akt/mTOR signaling pathway
Oncology Letters
·
2017
·
63 cit.
·
DOI
8
Discovery of Potent and Selective WDR5 Proteolysis Targeting Chimeras as Potential Therapeutics for Pancreatic Cancer
Journal of Medicinal Chemistry
·
2023
·
50 cit.
·
DOI
9
Transforming growth factor-β receptors localize to caveolae and regulate endothelial nitric oxide synthase in normal human endothelial cells
Biochemical Journal
·
2005
·
41 cit.
·
DOI
10
The oncogenic receptor ErbB2 modulates gemcitabine and irinotecan/SN-38 chemoresistance of human pancreatic cancer cells <i>via</i> hCNT1 transporter and multidrug-resistance associated protein MRP-2
Oncotarget
·
2015
·
41 cit.
·
DOI
Show 46 more papers
Feedback
PATL1/PAT1b (D8P1B) Rabbit Monoclonal Antibody — Evidence — PubIndex